Utah Medical Products (Utah Medical Products) Change In Working Capital

: $-0.23 Mil (TTM As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

Utah Medical Products's change in working capital for the quarter that ended in Dec. 2023 was $0.35 Mil.

Utah Medical Products's change in working capital for the fiscal year that ended in Dec. 2023 was $-0.23 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Utah Medical Products Change In Working Capital Historical Data

The historical data trend for Utah Medical Products's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Utah Medical Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

-4.32

1.99

-1.01

-2.23

-0.23

Utah Medical Products Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Working Capital	Get a 7-Day Free Trial															-0.71	0.89	-0.96	-0.50	0.35

Utah Medical Products Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.23 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Utah Medical Products Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Utah Medical Products's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Utah Medical Products (Utah Medical Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Utah Medical Products Inc (NAS:UTMD) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

UTM:Germany

Address

7043 South 300 West, Midvale, UT, USA, 84047

Website

http://www.utahmed.com

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.

Executives

Paul O Richins	director, officer: VP, Treasurer, Asst. Secretary	7043 SOUTH 300 WEST, MIDVALE UT 84047
Barbara A Payne	director
Ernst G Hoyer	director
Kevin L Cornwell	director, officer: Chairman, CEO, Secretary
Brian Koopman	officer: Principal Financial Officer	108 E 1700 S, BOUNTIFUL UT 84010
James H Beeson	director	7043 SOUTH 300 WEST, MIDVALE UT 84047
Greg A Leclaire	officer: Chief Financial Officer	5225 WILEY POST WAY, SUITE 500, SALT LAKE CITY UT 84116
Stephen W Bennett	director